PACB SCHEDULE 13G: SEC filing
A Schedule 13G was
Filed with the SEC on · accession 0000080255-26-000673
PACB filed a SCHEDULE 13G (schedule 13g) with the SEC on Nov 6, 2026. A Schedule 13G was filed regarding Pacific Biosciences of California, Inc. (PACB), indicating a passive ownership position by an institutional or other holder. The stock moved -7.2% by the first close after the filing.
Summary of the filing
A Schedule 13G was filed regarding Pacific Biosciences of California, Inc. (PACB), indicating a passive ownership position by an institutional or other holder. The filing does not disclose any activist intent or material corporate event.
Key details
How PACB stock reacted
Close before
$2.43
Nov 5, 2026
First close after
-7.20%
$2.25
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for PACB, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for PACB?
Click hereFrequently asked questions
What did PACB file with the SEC on Nov 6, 2026?
PACB filed a SCHEDULE 13G (SEC filing). A Schedule 13G was filed regarding Pacific Biosciences of California, Inc. (PACB), indicating a passive ownership position by an institutional or other holder. The filing does not disclose any activist intent or material corporate event.
How do I read a SCHEDULE 13G?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).
How did PACB stock react to this filing?
PACB closed at $2.43 before the filing and $2.25 on Nov 6, 2026 (-7.20%).
Other PACB SEC filings
Get alerts when PACB files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days